Our free daily oncology focused e-news service.
Subscribe» | Search Archives»
(Reuters) Oct 21, 2014 - A British-led petition signed by 29,000 people has demanded that Switzerland's Roche, the world's biggest maker of cancer medicines, cut the price of its expensive new breast cancer drug Kadcyla.
read article »
(Mayo Clinic) Oct 21, 2014 - After following breast cancer patients for an average of eight-plus years, researchers say that adding trastuzumab (Herceptin) to chemotherapy significantly improved the overall and disease-free survival of women with early stage HER2-positive breast cancer.
read press release »
News Story Commentary By Academic and Community Oncologists
Learn more about the OBR training platform, developed to provide an in-depth understanding of the unique business dynamics of today's oncology landscape.
OBR Job Board
Bayer Biopharmaceuticals, Inc. has posted 20 new jobs.
Ipsen Biopharmaceuticals, Inc. has posted over 50 new jobs.
Novocure has posted 4 jobs.